Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Keeping medication costs manageable in a year of economic pressures
Despite inflation and price hikes across many commonly used drugs, the employer-sponsored insurance market continues to deliver meaningful stability – and even savings – thanks to strong cost management strategies.
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
In this episode of "Health Unscripted," Eva Borden, president of Evernorth Behavioral Health, emphasizes the need for U.S. employers to leverage their influence through health insurance, workplace culture, and community engagement to change the crisis trajectory.
Plan sponsors can support expecting mothers aged 35+ with prenatal care, despite long-standing assumptions their pregnancies are high risk.
Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.
Evernorth Health Services has introduced Evernorth Oncology Benefit Services, which will be available to eligible commercial plan sponsors in 2025, with plans to expand over time.
